SARA SARGENT: Open Payments
NPI 1083803779 · LANCASTER, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$598 in 35 payments from 12 companies in 2025. Trend: 2023 $439 · 2024 $272 · 2025 $598
Food & beverage: $598
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 18 | $272 |
| PFIZER INC. | 3 | $52 |
| Corcept Therapeutics | 2 | $46 |
| Antares Pharma, Inc. | 2 | $42 |
| Novo Nordisk Inc | 2 | $36 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $34 |
| Exact Sciences Corporation | 2 | $29 |
| Otsuka America Pharmaceutical, Inc. | 1 | $21 |
| Verona Pharma, Inc. | 1 | $19 |
| Astellas Pharma US Inc | 1 | $16 |
Products named: QULIPTA, UBRELVY, NURTEC ODT, Korlym, XYOSTED, CAPLYTA, Cologuard Collection Kit, Ozempic.
Industry payments across OH — which companies pay providers there.
